Dr. Chiara Elena - CML - Chronic myeloid leukemia
Researcher at the Policlinico San Matteo Pavia Fondazione IRCCS
ARTICLES
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation
November 9, 2020, Journal of clinical medicine
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation
November 5, 2020, Blood
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life
June 8, 2020, Blood Cancer Journal
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP
December 23, 2019, Blood Advances
Gimema Registry of Conception/Pregnancy in Adult Italian Patients Diagnosed with Chronic Myeloid Leukemia (CML): Report on 166 Outcomes
November 29, 2018, Blood
Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Ponatinib in the Real-Life Practice: Prophylaxis and Identification of Risk Factors
November 29, 2018, Blood
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation
November 9, 2020, Journal of clinical medicine
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation
November 5, 2020, Blood
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life
June 8, 2020, Blood Cancer Journal
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP
December 23, 2019, Blood Advances
Gimema Registry of Conception/Pregnancy in Adult Italian Patients Diagnosed with Chronic Myeloid Leukemia (CML): Report on 166 Outcomes
November 29, 2018, Blood
Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Ponatinib in the Real-Life Practice: Prophylaxis and Identification of Risk Factors
November 29, 2018, Blood